ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $494,437 | +22.5% | 18,218 | +38.8% | 0.01% | +40.0% |
| Q2 2023 | $403,555 | -14.8% | 13,128 | -0.1% | 0.01% | -28.6% |
| Q1 2023 | $473,542 | -8.4% | 13,143 | +0.5% | 0.01% | -12.5% |
| Q4 2022 | $516,922 | +80.7% | 13,080 | +84.0% | 0.01% | +60.0% |
| Q3 2022 | $286,000 | -2.1% | 7,108 | +2.2% | 0.01% | -16.7% |
| Q2 2022 | $292,000 | -68.0% | 6,955 | -70.3% | 0.01% | -60.0% |
| Q1 2022 | $912,000 | -1.3% | 23,397 | +1.0% | 0.02% | +7.1% |
| Q4 2021 | $924,000 | +12.1% | 23,175 | +1.7% | 0.01% | -12.5% |
| Q3 2021 | $824,000 | -16.9% | 22,794 | -5.7% | 0.02% | -11.1% |
| Q2 2021 | $991,000 | +58.1% | 24,172 | +68.1% | 0.02% | +38.5% |
| Q1 2021 | $627,000 | +164.6% | 14,379 | +203.4% | 0.01% | +160.0% |
| Q4 2020 | $237,000 | – | 4,739 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |